Johnson & Johnson Segments Total — Total Assets decreased by 0.8% to $160.92B in Q3 2025 compared to the prior quarter.
An increase suggests capital expansion or acquisition activity, while a decrease may indicate asset divestiture or improved capital efficiency.
This metric represents the aggregate book value of all resources controlled by the business segments, including property...
Comparable to total assets reported by diversified healthcare conglomerates or large-cap industrial peers.
jnj_segment_segments_total_assets| Q1 '22 | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|
| Value | $142.83B | $153.46B | $133.03B | $141.39B | $143.84B | $162.23B | $160.92B |
| QoQ Change | — | +7.4% | -13.3% | +6.3% | +1.7% | +12.8% | -0.8% |
| YoY Change | — | — | -13.3% | +6.3% | — | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.